Navigation Links
New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
Date:5/30/2013

San Diego, CA (PRWEB) May 30, 2013

AttorneyOne.com, a recognized authority on law, updated the website recently and it is now actively providing expert opinion in view of the recent news on Granuflo Lawsuits.

According to court documents, on May 17, 2013 a daughter filed a lawsuit in Massachusetts District Court (case no. 1:2013cv11215) alleging that her mother suffered a fatal cardiac arrest caused by Granuflo and Naturalyte dialysis treatments. Granuflo, manufactured by Fresenius Medical Care, is an additive used in kidney dialysis to help patients maintain their bicarbonate levels which neutralize the acid buildup in the bloodstream during dialysis.

On April 23, 2013 the children of a woman filed a lawsuit in Louisiana Western District Court (case no. 5:2013cv00829) alleging that their mother died as a result of using Granuflo and NaturaLyte. In the lawsuit plaintiffs claim that, during hemodialysis at a Fresenius medical center, their mother suffered a cardiac event and she died of a heart attack a few hours later.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Granuflo severe complications. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Granuflo lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

Court data updated on May 14, 2013, by the US Judicial Panel on Multi-District Litigation (MDL), indicate that there are 161 actions pending in the Granuflo/Naturalyte MDL (MDL 2428, U.S. District Court for the District of Massachusetts). All the actions in the MDL involve similar allegations that plaintiffs suffered injury or death caused by the use of GranuFlo and/or NaturaLyte during hemodialysis, which allegedly may cause metabolic alkalosis in patients resulting in low blood pressure, hypokalemia, hypoxemia, hypercapnia, cardiac arrhythmia, or cardiopulmonary arrest.

AttorneyOne.com has further information on Granuflo lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/5/prweb10773984.htm

Read the full story at http://www.prweb.com/releases/2013/5/prweb10783818.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
3. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
4. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
5. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
6. Grant funds cardiac stem cell research for Duchenne muscular dystrophy-related heart disease
7. Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles
8. Study suggests new role for ECMO in treating patients with cardiac arrest and profound shock
9. Estrogen Levels Tied to Risk for Sudden Cardiac Death in Study
10. Study finds survival from cardiac arrest highest in the operating room or post-anesthesia care unit
11. Common Heart Meds May Boost Recovery From Non-Cardiac Surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... 24, 2017 , ... The Smart Machine Age is here, and it’s disrupting ... percent of all jobs in the United States may be taken over by technology ... the aggressive know-it-all who steamrolls over colleagues is drawing to a close. Success will ...
(Date:2/24/2017)... Australia (PRWEB) , ... February 24, 2017 , ... The ... AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes ... stress disorder and his attempts to overcome them. , Schanssema, initially unsure of ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology: